Last Updated on August 14, 2025 by The Health Master
USFDA inspection
The U.S. Food and Drug Administration inspection (USFDA inspection) has been successfully completed at Torrent Pharmaceuticals of its manufacturing facility in Vizag, Andhra Pradesh.
The company announced that the USFDA inspection was conducted from July 28 to August 1, 2025, and was concluded with zero observations.
Zero observations:
The USFDA inspection is a rigorous and comprehensive process designed to evaluate that pharmaceutical facilities comply with the highest standards of Good Manufacturing Practices (GMP).
A “zero observation” during the USFDA inspection means the said pharma company is complying with all possible regulation requirements.
This achievement not only indicates the reputation of Torrent Pharma but also shows that the company is manufacturing high-quality drugs for the safety and security of the patients.
Pharmaceutical Excellence
Torrent Pharmaceuticals Headquartered in Ahmedabad, Gujarat, it has a long legacy of over four decades in the Indian pharmaceutical industry.
The company is focusing on branded and generic drugs across various therapeutic areas.
Its robust portfolio includes a strong presence in cardiovascular care, central nervous system disorders, and diabetes care.
Q: What does a “zero observation” USFDA inspection mean?
A: A “zero observation” during the USFDA inspection means the said pharma company is complying with all possible regulation requirements.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
USFDA inspection: At Granules India arm with 1 observation
USFDA inspection: At Senores Pharma arm with 3 observations
USFDA inspection: At Unichem with 3 observations: Roha
USFDA inspection: At Natco Pharma with 7 observations: Hyderabad
USFDA inspection: At Sun Pharma with 8 observations: Halol
USFDA inspection: At Alembic Pharma with 4 observations: Panelav
Govt. appoints Adnl. DGHS as the Compounding Authority
USFDA inspection: At Granules India arm with 1 observation
Amendment: Know About the Cosmetics (Amendment) Rules, 2025
USFDA inspection: At Senores Pharma arm with 3 observations
Drug recall: Sun Pharma, Lupin, Dr. Reddy’s recall drugs
Ranitidine Under Scrutiny Over NDMA Concerns
NPPA directs Pharma industry on MRP of Non-Scheduled Formulations
All Medical Stores to install CCTV cameras: Delhi
India Inspects 905 Pharma firms: Action Against 694
